Evidence map›Paper›PMID 31405229›Full record

ReviewPharmaceutics2019

Bio-Functional Textiles: Combining Pharmaceutical Nanocarriers with Fibrous Materials for Innovative Dermatological Therapies.

Daniele Massella, Monica Argenziano, Ada Ferri, Jinping Guan, Stéphane Giraud, Roberta Cavalli, Antonello A Barresi, Fabien Salaün

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Safety in Cosmetics and Cosmetovigilance, Current Regulations in Türkiye.Turkish journal of pharmaceutical sciences · 2022
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniele MassellaENSAIT, GEMTEX-Laboratoire de Génie et Matériaux Textiles, F-59000 Lille, France. daniele.massella@ensait.fr.
Monica ArgenzianoDepartment of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125 Torino, Italy.
Ada FerriDepartment of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino (TO), Italy.
Jinping GuanCollege of Textile and Clothing Engineering, Soochow University, Suzhou 215123, China.
Stéphane GiraudENSAIT, GEMTEX-Laboratoire de Génie et Matériaux Textiles, F-59000 Lille, France.
Roberta CavalliDepartment of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125 Torino, Italy.
Antonello A BarresiDepartment of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino (TO), Italy.
Fabien SalaünENSAIT, GEMTEX-Laboratoire de Génie et Matériaux Textiles, F-59000 Lille, France.

Funding

Education, Audiovisual and Culture Executive Agency Erasmus Mundus Joint Doctorate in Sustainable Management and Design of Textiles (SMD-Tex)
6 · The paper itself

Abstract

In the field of pharmaceutical technology, significant attention has been paid on exploiting skin as a drug administration route. Considering the structural and chemical complexity of the skin barrier, many research works focused on developing an innovative way to enhance skin drug permeation. In this context, a new class of materials called bio-functional textiles has been developed. Such materials consist of the combination of advanced pharmaceutical carriers with textile materials. Therefore, they own the possibility of providing a wearable platform for continuous and controlled drug release. Notwithstanding the great potential of these materials, their large-scale application still faces some challenges. The present review provides a state-of-the-art perspective on the bio-functional textile technology analyzing the several issues involved. Firstly, the skin physiology, together with the dermatological delivery strategy, is keenly described in order to provide an overview of the problems tackled by bio-functional textiles technology. Secondly, an overview of the main dermatological nanocarriers is provided; thereafter the application of these nanomaterial to textiles is presented. Finally, the bio-functional textile technology is framed in the context of the different dermatological administration strategies; a comparative analysis that also considers how pharmaceutical regulation is conducted.

Indexed as

biomedical materialselectrospinningencapsulationfibersnanocarriersregulatory issuesskintextilestransdermal drug delivery

Identifiers

PMID31405229
PMCPMC6723157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.